Minimal Residual Disease in Acute Lymphoblastic Leukemia

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
Minimal Residual Disease in Acute Lymphoblastic Leukemia ; volume:42 ; number:01 ; year:2021 ; pages:071-076
Indian journal of medical & paediatric oncology ; 42, Heft 01 (2021), 071-076

Beteiligte Personen und Organisationen
Patil, Pratik P.
Jafa, Esha
Aggarwal, Mayank

DOI
10.1055/s-0041-1729730
URN
urn:nbn:de:101:1-2021081213371734029613
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:54 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Patil, Pratik P.
  • Jafa, Esha
  • Aggarwal, Mayank

Ähnliche Objekte (12)

Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia

Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia

Detection of minimal residual disease in childhood acute lymphoblastic leukemia by digital droplet PCR

Detection of minimal residual disease in childhood acute lymphoblastic leukemia by digital droplet PCR

Advanced minimal residual disease monitoring for acute lymphoblastic leukemia with multiplex mediator probe PCR

Advanced minimal residual disease monitoring for acute lymphoblastic leukemia with multiplex mediator probe PCR

Acute lymphoblastic leukemia

Acute lymphoblastic leukemia

Testing for minimal residual disease in adults with acute lymphoblastic leukemia in Europe: a clinician survey

Testing for minimal residual disease in adults with acute lymphoblastic leukemia in Europe: a clinician survey

Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia

Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia

Relapsed Acute Lymphoblastic Leukemia

Relapsed Acute Lymphoblastic Leukemia

Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia

Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia

Clinicians’ Perspectives on Cure in Adult Patients with Acute Lymphoblastic Leukemia with Minimal Residual Disease: A Delphi Study

Clinicians’ Perspectives on Cure in Adult Patients with Acute Lymphoblastic Leukemia with Minimal Residual Disease: A Delphi Study

Effect of Dose and Schedule of L-Asparaginase Administration on Early Minimal Residual Disease in Acute Lymphoblastic Leukemia

Effect of Dose and Schedule of L-Asparaginase Administration on Early Minimal Residual Disease in Acute Lymphoblastic Leukemia

Monitoring Minimal Residual Disease in RUNX1 -Mutated Acute Myeloid Leukemia

Monitoring Minimal Residual Disease in RUNX1 -Mutated Acute Myeloid Leukemia

Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma

Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma

Verbundene Objekte